183 related articles for article (PubMed ID: 6734031)
1. Cefonicid kinetics in subjects with normal and impaired renal function.
Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cefonicid in uraemic patients.
Fillastre JP; Fourtillan JB; Leroy A; Ramis N; Lefevre MA; Reumont G; Humbert G
J Antimicrob Chemother; 1986 Aug; 18(2):203-11. PubMed ID: 3759731
[TBL] [Abstract][Full Text] [Related]
3. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
Phelps RT; Conte JE
Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic disposition of cefonicid in patients with renal failure and receiving hemodialysis.
Barriere SL; Gambertoglio JG; Alexander DP; Stagg RJ; Conte JE
Rev Infect Dis; 1984; 6 Suppl 4():S809-15. PubMed ID: 6522922
[TBL] [Abstract][Full Text] [Related]
5. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
Matzke GR; Abraham PA; Halstenson CE; Keane WF
Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
[TBL] [Abstract][Full Text] [Related]
6. Ceforanide kinetics in renal insufficiency.
Hawkins SS; Alford RH; Stone WJ; Smyth RD; Pfeffer M
Clin Pharmacol Ther; 1981 Oct; 30(4):468-74. PubMed ID: 7285481
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and renal handling of cefonicid.
Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
[TBL] [Abstract][Full Text] [Related]
8. Cefmenoxime pharmacokinetics in patients with renal insufficiency.
Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW
Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752
[TBL] [Abstract][Full Text] [Related]
9. The pharmacology of cefamandole in patients with reduced renal function.
Czerwinski AW; Pederson JA
Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
[TBL] [Abstract][Full Text] [Related]
10. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
[TBL] [Abstract][Full Text] [Related]
11. Cefamandole pharmacokinetics and dosage adjustments in relation to renal function.
Brogard JM; Kopferschmitt J; Spach MO; Grudet O; Lavillaureix J
J Clin Pharmacol; 1979 Jul; 19(7):366-77. PubMed ID: 479381
[TBL] [Abstract][Full Text] [Related]
12. Effect of age and renal function on cefonicid pharmacokinetics.
Trang JM; Monson TP; Ackerman BH; Underwood FL; Manning JT; Kearns GL
Antimicrob Agents Chemother; 1989 Feb; 33(2):142-6. PubMed ID: 2719458
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
Blum RA; Kohli RK; Harrison NJ; Schentag JJ
Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal transport of cefonicid.
Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
[TBL] [Abstract][Full Text] [Related]
15. Cefsulodin pharmacokinetics in patients with various degrees of renal function.
Matzke GR; Keane WF
Antimicrob Agents Chemother; 1983 Mar; 23(3):369-73. PubMed ID: 6847169
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH
J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
[TBL] [Abstract][Full Text] [Related]
17. An overview of pharmacokinetics.
Cutler RE
Rev Infect Dis; 1984; 6 Suppl 4():S803-8. PubMed ID: 6522921
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of cefonicid, a new broad-spectrum cephalosporin.
Barriere SL; Hatheway GJ; Gambertoglio JG; Lin ET; Conte JE
Antimicrob Agents Chemother; 1982 Jun; 21(6):935-8. PubMed ID: 7114840
[TBL] [Abstract][Full Text] [Related]
19. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function.
St Peter JV; Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677
[TBL] [Abstract][Full Text] [Related]
20. Isepamicin disposition in subjects with various degrees of renal function.
Halstenson CE; Kelloway JS; Affrime MB; Lin CC; Teal MA; Shapiro BE; Awni WM
Antimicrob Agents Chemother; 1991 Nov; 35(11):2382-7. PubMed ID: 1804011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
